SNDX logo

Syndax Pharmaceuticals, Inc. (SNDX) Shareholders equity

annual shareholders equity:

$288.12M-$266.07M(-48.01%)
December 31, 2024

Summary

  • As of today (September 16, 2025), SNDX annual stockholders equity is $288.12 million, with the most recent change of -$266.07 million (-48.01%) on December 31, 2024.
  • During the last 3 years, SNDX annual shareholders equity has fallen by -$120.24 million (-29.45%).
  • SNDX annual shareholders equity is now -48.01% below its all-time high of $554.20 million, reached on December 31, 2023.

Performance

SNDX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNDXbalance sheet metrics

quarterly shareholders equity:

$157.42M-$57.63M(-26.80%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SNDX quarterly stockholders equity is $157.42 million, with the most recent change of -$57.63 million (-26.80%) on June 30, 2025.
  • Over the past year, SNDX quarterly shareholders equity has dropped by -$276.91 million (-63.76%).
  • SNDX quarterly shareholders equity is now -71.59% below its all-time high of $554.20 million, reached on December 31, 2023.

Performance

SNDX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNDXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SNDX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-48.0%-63.8%
3 y3 years-29.4%-56.5%
5 y5 years+811.8%+6.6%

SNDX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-48.0%at low-71.6%at low
5 y5-year-48.0%+811.8%-71.6%+19.3%
alltimeall time-48.0%+1083.8%-71.6%+3613.9%

SNDX Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$157.42M(-26.8%)
Mar 2025
-
$215.06M(-25.4%)
Dec 2024
$288.12M(-48.0%)
$288.12M(-21.4%)
Sep 2024
-
$366.43M(-15.6%)
Jun 2024
-
$434.34M(-11.7%)
Mar 2024
-
$491.89M(-11.2%)
Dec 2023
$554.20M(+18.6%)
$554.20M(+54.3%)
Sep 2023
-
$359.19M(-10.2%)
Jun 2023
-
$400.04M(-8.1%)
Mar 2023
-
$435.50M(-6.8%)
Dec 2022
$467.45M(+14.5%)
$467.45M(+38.3%)
Sep 2022
-
$338.10M(-6.6%)
Jun 2022
-
$361.94M(-3.4%)
Mar 2022
-
$374.55M(-8.3%)
Dec 2021
$408.37M(+61.9%)
$408.37M(+105.2%)
Sep 2021
-
$199.00M(-7.3%)
Jun 2021
-
$214.56M(-6.0%)
Mar 2021
-
$228.21M(-9.5%)
Dec 2020
$252.19M(+698.1%)
$252.19M(+91.1%)
Sep 2020
-
$131.98M(-10.6%)
Jun 2020
-
$147.65M(+175.9%)
Mar 2020
-
$53.51M(+69.3%)
Dec 2019
$31.60M
$31.60M(-28.3%)
DateAnnualQuarterly
Sep 2019
-
$44.04M(-20.3%)
Jun 2019
-
$55.27M(-19.5%)
Mar 2019
-
$68.63M(+29.4%)
Dec 2018
$53.05M(-49.1%)
$53.05M(-17.5%)
Sep 2018
-
$64.27M(-8.6%)
Jun 2018
-
$70.35M(-19.1%)
Mar 2018
-
$86.95M(-16.6%)
Dec 2017
$104.32M(+24.0%)
$104.32M(+7.9%)
Sep 2017
-
$96.71M(-11.5%)
Jun 2017
-
$109.34M(+50.6%)
Mar 2017
-
$72.61M(-13.7%)
Dec 2016
$84.14M(+26.1%)
$84.14M(-10.3%)
Sep 2016
-
$93.83M(-11.7%)
Jun 2016
-
$106.24M(-6.7%)
Mar 2016
-
$113.85M(-4516.1%)
Dec 2015
$66.70M(-1266.9%)
-
Dec 2014
-$5.72M(-148.2%)
-
Sep 2014
-
-$2.58M(-159.8%)
Jun 2014
-
$4.31M(-48.9%)
Mar 2014
-
$8.43M(-28.8%)
Dec 2013
$11.85M(-140.5%)
$11.85M(-364.5%)
Sep 2013
-
-$4.48M
Dec 2012
-$29.29M(+53.7%)
-
Dec 2011
-$19.05M
-

FAQ

  • What is Syndax Pharmaceuticals, Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for Syndax Pharmaceuticals, Inc.?
  • What is Syndax Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
  • What is Syndax Pharmaceuticals, Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Syndax Pharmaceuticals, Inc.?
  • What is Syndax Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

What is Syndax Pharmaceuticals, Inc. annual stockholders equity?

The current annual shareholders equity of SNDX is $288.12M

What is the all time high annual shareholders equity for Syndax Pharmaceuticals, Inc.?

Syndax Pharmaceuticals, Inc. all-time high annual stockholders equity is $554.20M

What is Syndax Pharmaceuticals, Inc. annual shareholders equity year-on-year change?

Over the past year, SNDX annual stockholders equity has changed by -$266.07M (-48.01%)

What is Syndax Pharmaceuticals, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of SNDX is $157.42M

What is the all time high quarterly shareholders equity for Syndax Pharmaceuticals, Inc.?

Syndax Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $554.20M

What is Syndax Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

Over the past year, SNDX quarterly stockholders equity has changed by -$276.91M (-63.76%)
On this page